PDE4D longform selective, allosteric compounds are under investigation for a range of brain disorders [39, 40] and their selectivity arises from a single amino acid difference (PDE4D vs PDE4A, 4B, 4C) in the UCR2 region [6]. This evidence concerns the gene PDE4D and brain disorder.